GlobeNewswire: MediPharm Labs Corp. Contains the last 10 of 210 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T22:31:26ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2022/01/05/2361498/0/en/MediPharm-Labs-Completes-Payment-of-All-Convertible-Debt.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Completes Payment of All Convertible Debt2022-01-05T12:00:00Z<![CDATA[TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it has completed all payments required under its 2020 $41 million unsecured convertible debt.]]>https://www.globenewswire.com/news-release/2021/12/22/2356639/0/en/MediPharm-Labs-Receives-Award-for-CBD-Brand-of-the-Year.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Receives Award for CBD Brand of the Year2021-12-22T12:00:00Z<![CDATA[BARRIE, Ontario, Dec. 22, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it has been awarded best CBD brand of the year by Kind Magazine.]]>Kind Awards 2021 CBD Brand of the YearKind Awards 2021 CBD Brand of the Yearhttps://www.globenewswire.com/news-release/2021/12/21/2355959/0/en/MediPharm-Labs-Provides-Operational-Update-and-Confirms-Profitability-Improvement-Initiatives-are-Underway.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Provides Operational Update and Confirms Profitability Improvement Initiatives are Underway2021-12-21T12:00:00Z<![CDATA[TORONTO, Dec. 21, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to provide an update on the significant strategic profitability improvement initiatives underway at the Company.]]>https://www.globenewswire.com/news-release/2021/12/07/2347250/0/en/MediPharm-Labs-Announces-Changes-to-Board-of-Directors.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Announces Changes to Board of Directors2021-12-07T12:00:00Z<![CDATA[BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce changes to its Board of Directors (the “Board”).]]>https://www.globenewswire.com/news-release/2021/11/26/2341458/0/en/MediPharm-Labs-Completes-Medical-Cannabis-Export-to-Barbados.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Completes Medical Cannabis Export to Barbados2021-11-26T12:00:00Z<![CDATA[BARRIE, Ontario, Nov. 26, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a medical cannabis export to Barbados in conjunction with strategic partner Avicanna (TSX: AVCN).]]>https://www.globenewswire.com/news-release/2021/11/23/2339719/0/en/MediPharm-Labs-Expands-CBN-Portfolio-with-Two-New-Products.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Expands CBN Portfolio with Two New Products 2021-11-23T12:15:00Z<![CDATA[BARRIE, Ontario, Nov. 23, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the expansion of its unique cannabinol (“CBN”) product line.]]>https://www.globenewswire.com/news-release/2021/11/15/2334125/0/en/MediPharm-Reports-Third-Quarter-2021-Results-Announces-New-CEO-to-Start-Today.html?f=22&fvtc=4&fvtv=46964MediPharm Reports Third Quarter 2021 Results; Announces New CEO to Start Today2021-11-15T12:15:00Z<![CDATA[BARRIE, Ontario, Nov. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids today announced its financial results for the three and nine months ended September 30, 2021, a period of transition in establishing itself as an international pharmaceutical company specializing in cannabis.]]>https://www.globenewswire.com/news-release/2021/11/10/2331340/0/en/MediPharm-Labs-Sets-Date-to-Report-Third-Quarter-2021-Financial-Results.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Sets Date to Report Third Quarter 2021 Financial Results2021-11-10T12:00:00Z<![CDATA[TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release third quarter financial results for the three and nine month period ended September 30, 2021 before markets open on Monday, November 15, 2021.]]>https://www.globenewswire.com/news-release/2021/10/21/2318171/0/en/MediPharm-Labs-Appoints-New-Chief-Executive-Officer.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Appoints New Chief Executive Officer2021-10-21T11:00:00Z<![CDATA[BARRIE, Ontario, Oct. 21, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that Bryan Howcroft will join MediPharm Labs as Chief Executive Officer and Director, effective November 15, 2021.]]>https://www.globenewswire.com/news-release/2021/10/19/2316349/0/en/MediPharm-Labs-Completes-a-New-Cannabis-Oil-Delivery-to-German-Partner-Vayamed.html?f=22&fvtc=4&fvtv=46964MediPharm Labs Completes a New Cannabis Oil Delivery to German Partner Vayamed2021-10-19T11:00:00Z<![CDATA[BARRIE, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce another GMP cannabis extract delivery to Germany. This delivery of formulated oil bottles further establishes the Company’s position as a leader in the wholesale of GMP cannabis oil to the European Union’s largest medical cannabis jurisdiction. This export is a key milestone in the Company’s goal of leveraging its pharmaceutical GMP licenses to increase consistent international medical sales.]]>